ella | Prescribing Info for Healthcare Professionals

This site is intended for US residents only.

Healthcare professional website

Go to
Patient website

Meet ella ▼

Prescribing ella ▼

Patient counseling information

Resources ▼

Healthcare provider brochure

Patient brochure

Patient Information

Prescribing Information

if your patients aren't ready

ella is

Available in all 50 states, ella is the only emergency contraceptive pill with proven efficacy when the risk of pregnancy is at its highest.¹

Advanced Prescriptions What to Know

about ella

With a 5-day window of efficacy,² a prescription for ella provides a line of defense against unplanned pregnancy.

when it comes to prevention,

ella is one of a kind

ella is the only emergency contraceptive pill that is proven effective even when the risk of pregnancy is at its highest.¹

Be prepared to prescribe

the right tools for prevention

Here are a few important guidelines to know prior to prescribing ella to patients for emergencies or advanced contraceptive need.

Key facts about ella

Helpful resources regarding ella

Review our collection of clinical guidelines and informational handouts for you and your patients.

Healthcare Provider Leave-Behind

Download

Patient Info Brochure

Download

+

Important Safety Information

Indication: ella® (ulipristal acetate) is a progesterone agonist/antagonist emergency contraceptive indicated for prevention of pregnancy following unprotected intercourse or a known or suspected contraceptive failure. ella® is not intended for routine contraceptive use.

Contraindications: ella® should not be used in those who are pregnant or are suspected to be pregnant.

Warnings and Precautions:

Existing Pregnancy: ella® is not indicated for termination of an existing pregnancy.
Ectopic pregnancy: Women who become pregnant or complain of lower abdominal pain after taking ella® should be evaluated for the possibility of ectopic pregnancy.
Fertility Following Use: Rapid return of fertility is likely. Subsequent acts of intercourse should be protected by a reliable barrier method of contraception until the next menstrual period.
Effect on Menstrual Cycle: ella® may alter the next expected menses. If menses is delayed beyond 1 week, pregnancy should be ruled out. ella® should not be taken more than once in the same menstrual cycle.
Breastfeeding: ella® is not recommended for use in those who are breastfeeding.

ella® does not protect against sexually transmitted diseases (STDs) or HIV infection (AIDS).

The most common adverse reactions (>5%) are: headache (18%), abdominal pain (12%), nausea (12%), dysmenorrhea (9%), fatigue (6%), and dizziness (5%).

Drug Interactions: Because ella® and the progestin component of hormonal contraceptives both bind to the progesterone receptor, using them together could reduce their contraceptive effectiveness. Patients should be counseled that they should not use hormonal contraceptives for at least 5 days after intake of ella® and to use a reliable barrier method of contraception for subsequent acts of intercourse during this time period. Drugs or herbal products that induce CYP3A4 may decrease the effectiveness of ella®.

For more information, please see the full Prescribing Information.

[ close this box ]